add certainty to your toxicology

12
TOXICOLOGY PANELS 317-759-4TOX | AXISFORTOX.COM | [email protected] Drugs of Abuse Panel Comprehensive Panel Primary matrix: blood, vitreous, fluid, tissue Urine Qualitative Panel available Whole case approach (see reverse) Drug classes analyzed 9 25 Maximum analytes (see analyte table) 50+ 300+ Analyte Assurance™ Analyte Assurance™, a feature of the Comprehensive Panel. If Axis observes a potentially positive novel substance [Designer Opioids, Novel Psychoactives, Synthetic Cannabinoids, Novel Emerging], we will contact you to offer the relevant confirmation panel. Benefits include: ensures novel substances do not go undetected pay only for the confirmation IF ORDERED. testing proceeds in parallel with Comprehensive panel to help close out cases in a shorter time period ADD CERTAINTY TO YOUR TOXICOLOGY See our Test Catalog at www.axisfortox.com for more information. SMR369, version 2.0

Upload: others

Post on 01-Dec-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

TOXICOLOGY PANELS

317-759-4TOX | AXISFORTOX.COM | [email protected]

Drugs of Abuse Panel Comprehensive Panel

Primary matrix: blood, vitreous, fluid, tissue

Urine Qualitative Panel available

Whole case approach (see reverse)

Drug classes analyzed 9 25

Maximum analytes (see analyte table) 50+ 300+

Analyte Assurance™

Analyte Assurance™, a feature of the Comprehensive Panel.

If Axis observes a potentially positive novel substance [Designer

Opioids, Novel Psychoactives, Synthetic Cannabinoids, Novel

Emerging], we will contact you to offer the relevant confirmation

panel. Benefits include:

ensures novel substances do not go undetected

pay only for the confirmation IF ORDERED.

testing proceeds in parallel with Comprehensive panel to help

close out cases in a shorter time period

ADD CERTAINTY TO YOUR TOXICOLOGY

See our Test Catalog at www.axisfortox.com

for more information.

SMR369, version 2.0

317-759-4TOX | AXISFORTOX.COM | [email protected]

While blood is the preferred matrix, there is significant benefit to testing multiple specimens. Testing in urine and vitreous can:

compensate for the quick metabolism of certain compounds such as 6-Acetylmorphine (2-3 hours in blood vs 8 hours in urine)

corroborate blood findings give attorneys additional certainty in litigation provide a complete picture of your case

Specimen

Blood Urine Vitreous

Testing Drugs of Abuse

OR Comprehensive

Basic Drugs of Abuse Qualitative

Vitreous Volatiles (if Ethanol positive in blood)

Benefits Recognized standard for

quantitation and concentration

Corroborates timeline and catches fast

metabolizing drugs

Mitigates effects of decomposition on

blood alcohol

Cost One Bundled Price Included with Blood Included with Blood

AXIS’ WHOLE CASE APPROACH

See our Test Catalog at www.axisfortox.com

for more information.

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VAmphetamine AMPHETAMINES XBenzphetamine (as Amphetamine) AMPHETAMINES XEphedrine AMPHETAMINES X X X XMDA AMPHETAMINES X X XMDEA AMPHETAMINES X X X XMDMA AMPHETAMINES X X XMethamphetamine AMPHETAMINES X X X XNorpseudoephedrine AMPHETAMINES X X XPhentermine AMPHETAMINES XPhenylpropanolamine AMPHETAMINES X X XPMA AMPHETAMINESPseudoephedrine AMPHETAMINES X X X XAcetaminophen ANALGESICSIbuprofen ANALGESICSIndomethacin ANALGESICSNaproxen ANALGESICSPhenacetin ANALGESICSPhenylbutazone ANALGESICSSalicylic Acid ANALGESICSBenzocaine ANESTHETICSBupivacaine ANESTHETICSEtomidate ANESTHETICSKetamine ANESTHETICSLidocaine ANESTHETICSMepivacaine ANESTHETICSMonoethylglycinexylidide (MEGX) ANESTHETICSNorketamine ANESTHETICSRopivacaine ANESTHETICSAtropine ANTICHOLINERGICSBenztropine ANTICHOLINERGICSDicyclomine ANTICHOLINERGICSDonepezil ANTICHOLINERGICSScopolamine ANTICHOLINERGICS10‐Hydroxycarbazepine ANTICONVULSANTSLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 1 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VCarbamazepine ANTICONVULSANTSCarbamazepine‐10,11‐epoxide ANTICONVULSANTSGabapentin ANTICONVULSANTSLacosamide ANTICONVULSANTSLamotrigine ANTICONVULSANTSLevetiracetam ANTICONVULSANTSMethsuximide ANTICONVULSANTSPhensuximide ANTICONVULSANTSPhenylethylmalonamide (PEMA) ANTICONVULSANTSPhenytoin ANTICONVULSANTSPregabalin ANTICONVULSANTSPrimidone ANTICONVULSANTSTopiramate ANTICONVULSANTSZonisamide ANTICONVULSANTSAmitriptyline ANTIDEPRESSANTSAmoxapine ANTIDEPRESSANTSBupropion ANTIDEPRESSANTSCitalopram/Escitalopram ANTIDEPRESSANTSClomipramine ANTIDEPRESSANTSDesipramine ANTIDEPRESSANTSDesmethylclomipramine ANTIDEPRESSANTSDesmethyldoxepin ANTIDEPRESSANTSDesmethylsertraline ANTIDEPRESSANTSDesmethyltrimipramine ANTIDEPRESSANTSDoxepin ANTIDEPRESSANTSDuloxetine ANTIDEPRESSANTSFluoxetine ANTIDEPRESSANTSFluvoxamine ANTIDEPRESSANTSHydroxybupropion ANTIDEPRESSANTSImipramine ANTIDEPRESSANTSMaprotiline ANTIDEPRESSANTSmeta‐Chlorophenylpiperazine (mCPP) ANTIDEPRESSANTSMirtazapine ANTIDEPRESSANTSNorfluoxetine ANTIDEPRESSANTSLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 2 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VNortriptyline ANTIDEPRESSANTSO‐Desmethylvenlafaxine ANTIDEPRESSANTSParoxetine ANTIDEPRESSANTSSertraline ANTIDEPRESSANTSTrazodone ANTIDEPRESSANTSTrimipramine ANTIDEPRESSANTSVenlafaxine ANTIDEPRESSANTSChlorpropamide ANTIDIABETICSGlimepiride ANTIDIABETICSGlipizide ANTIDIABETICSGlyburide ANTIDIABETICSItraconazole ANTIFUNGALSKetoconazole ANTIFUNGALSVoriconazole ANTIFUNGALSBrompheniramine ANTIHISTAMINESChlorpheniramine ANTIHISTAMINESDiphenhydramine ANTIHISTAMINESDoxylamine ANTIHISTAMINESHydroxyzine ANTIHISTAMINESLoratadine ANTIHISTAMINESPheniramine ANTIHISTAMINESPromethazine ANTIHISTAMINESPyrilamine ANTIHISTAMINESTetrahydrozoline ANTIHISTAMINESTriprolidine ANTIHISTAMINES9‐Hydroxyrisperidone ANTIPSYCHOTICSAripiprazole ANTIPSYCHOTICSBuspirone ANTIPSYCHOTICSChlorpromazine ANTIPSYCHOTICSClozapine ANTIPSYCHOTICSFluphenazine ANTIPSYCHOTICSHaloperidol ANTIPSYCHOTICSIloperidone ANTIPSYCHOTICSLoxapine ANTIPSYCHOTICSLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 3 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VMesoridazine ANTIPSYCHOTICSNorclozapine ANTIPSYCHOTICSOlanzapine ANTIPSYCHOTICSPerphenazine ANTIPSYCHOTICSProchlorperazine ANTIPSYCHOTICSPromazine ANTIPSYCHOTICSQuetiapine ANTIPSYCHOTICSRisperidone ANTIPSYCHOTICSThioridazine ANTIPSYCHOTICSTrifluoperazine ANTIPSYCHOTICSZiprasidone ANTIPSYCHOTICSAmobarbital/Pentobarbital BARBITURATES X X X XButabarbital BARBITURATES X X X XButalbital BARBITURATES X X X XPhenobarbital BARBITURATES X X X XSecobarbital BARBITURATES X X X X7‐Aminoclonazepam BENZODIAZEPINES X X X X7‐Aminoflunitrazepam BENZODIAZEPINESAlpha‐Hydroxyalprazolam BENZODIAZEPINES X X X XAlprazolam BENZODIAZEPINES X X X XBromazepam BENZODIAZEPINESChlordiazepoxide BENZODIAZEPINES X X X XClobazam BENZODIAZEPINESClonazepam BENZODIAZEPINES X X X XClonazolam BENZODIAZEPINESDelorazepam BENZODIAZEPINESDemoxepam BENZODIAZEPINESDesalkylflurazepam BENZODIAZEPINES X X X XDesmethylflunitrazepam BENZODIAZEPINESDiazepam BENZODIAZEPINES X X X XDiclazepam BENZODIAZEPINESEstazolam BENZODIAZEPINES X X X XEtizolam BENZODIAZEPINESFlubromazolam BENZODIAZEPINESLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 4 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VFlunitrazepam BENZODIAZEPINESFlurazepam BENZODIAZEPINES X X X XHydroxyethylflurazepam BENZODIAZEPINESHydroxytriazolam BENZODIAZEPINES X X XLorazepam BENZODIAZEPINES X X X XMedazepam BENZODIAZEPINESMidazolam BENZODIAZEPINES X X X XNordiazepam BENZODIAZEPINES X X X XOxazepam BENZODIAZEPINES X X X XPhenazepam BENZODIAZEPINESTemazepam BENZODIAZEPINES X X X XTriazolam BENZODIAZEPINES X X X XZolazepam BENZODIAZEPINESDelta‐9‐THC CANNABINOIDS X X X XTHC‐COOH CANNABINOIDS X X X XAcebutolol CARDIOVASCULARSAlprenolol CARDIOVASCULARSAmiodarone CARDIOVASCULARSAmlodipine CARDIOVASCULARSAtenolol CARDIOVASCULARSBetaxolol CARDIOVASCULARSBisoprolol CARDIOVASCULARSChlorothiazide CARDIOVASCULARSClonidine CARDIOVASCULARSDiltiazem CARDIOVASCULARSDisopyramide CARDIOVASCULARSEsmolol CARDIOVASCULARSFlecainide CARDIOVASCULARSFurosemide CARDIOVASCULARSHydrochlorothiazide CARDIOVASCULARSLabetalol CARDIOVASCULARSMetoprolol CARDIOVASCULARSMexiletine CARDIOVASCULARSN‐Acetylprocainamide CARDIOVASCULARSLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 5 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VNifedipine CARDIOVASCULARSOxprenolol CARDIOVASCULARSPapaverine CARDIOVASCULARSPentoxifylline CARDIOVASCULARSPindolol CARDIOVASCULARSProcainamide CARDIOVASCULARSPropranolol CARDIOVASCULARSReserpine CARDIOVASCULARSSotalol CARDIOVASCULARSTimolol CARDIOVASCULARSVerapamil CARDIOVASCULARSWarfarin CARDIOVASCULARS4‐ANPP DESIGNER OPIOIDSAcetyl Fentanyl DESIGNER OPIOIDSAcrylfentanyl DESIGNER OPIOIDSButyrl Fentanyl/Isobutyryl Fentanyl DESIGNER OPIOIDSCarfentanil DESIGNER OPIOIDScis‐3‐Methylfentanyl DESIGNER OPIOIDSCyclopropylfentanyl DESIGNER OPIOIDSFuranyl Fentanyl DESIGNER OPIOIDSMethoxyacetylfentanyl DESIGNER OPIOIDStrans‐3‐Methylfentanyl DESIGNER OPIOIDSU‐47700 DESIGNER OPIOIDSValeryl Fentanyl DESIGNER OPIOIDSLSD HALLUCINOGENSMescaline HALLUCINOGENSPhencyclidine HALLUCINOGENS X X X XSalvinorin B HALLUCINOGENSAtomoxetine MISCELLANEOUSCyclizine MISCELLANEOUSGuaifenesin MISCELLANEOUSLevamisole MISCELLANEOUSMemantine MISCELLANEOUSMetoclopramide MISCELLANEOUSLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 6 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VMitragynine MISCELLANEOUSQuinidine/Quinine MISCELLANEOUSStrychnine MISCELLANEOUSTrihexyphenidyl MISCELLANEOUSCarisoprodol MUSCLE RELAXANTS X X XCyclobenzaprine MUSCLE RELAXANTSLaudanosine MUSCLE RELAXANTSMeprobamate MUSCLE RELAXANTS X X X XMetaxalone MUSCLE RELAXANTSMethocarbamol MUSCLE RELAXANTSOrphenadrine MUSCLE RELAXANTSXylazine MUSCLE RELAXANTS25B‐NBOMe NOVEL PSYCHOACTIVES25C‐NBOMe NOVEL PSYCHOACTIVES25I‐NBOMe NOVEL PSYCHOACTIVES2C‐B NOVEL PSYCHOACTIVES2C‐E NOVEL PSYCHOACTIVES2C‐I NOVEL PSYCHOACTIVES5‐MeO‐DALT NOVEL PSYCHOACTIVESAlpha‐PVP NOVEL PSYCHOACTIVESButylone NOVEL PSYCHOACTIVESDibutylone NOVEL PSYCHOACTIVESDimethylone NOVEL PSYCHOACTIVESEthylone NOVEL PSYCHOACTIVESMDPV NOVEL PSYCHOACTIVESMephedrone NOVEL PSYCHOACTIVESMethcathinone NOVEL PSYCHOACTIVESMethedrone NOVEL PSYCHOACTIVESMethoxetamine NOVEL PSYCHOACTIVESMethylone NOVEL PSYCHOACTIVESN‐Ethyl Pentylone NOVEL PSYCHOACTIVESPentylone NOVEL PSYCHOACTIVESTFMPP NOVEL PSYCHOACTIVES6‐Acetylmorphine OPIOID ANALGESICS X X X XLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 7 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530V6‐Beta‐Naltrexol OPIOID ANALGESICSAlfentanil OPIOID ANALGESICSBuprenorphine OPIOID ANALGESICS X X X XButorphanol OPIOID ANALGESICSCodeine OPIOID ANALGESICS X X X XDesmethylloperamide OPIOID ANALGESICSDextro/Levo Methorphan OPIOID ANALGESICSDextrorphan/Levorphanol OPIOID ANALGESICSDihydrocodeine OPIOID ANALGESICS X X X XEDDP OPIOID ANALGESICS X X X XFentanyl OPIOID ANALGESICS X X X XHydrocodone OPIOID ANALGESICS X X X XHydromorphone OPIOID ANALGESICS X X XLoperamide OPIOID ANALGESICSMeperidine OPIOID ANALGESICSMethadone OPIOID ANALGESICS X X X XMorphine OPIOID ANALGESICS X X X XNalbuphine OPIOID ANALGESICSNaloxone OPIOID ANALGESICSNaltrexone OPIOID ANALGESICSNorbuprenorphine OPIOID ANALGESICS X X X XNorfentanyl OPIOID ANALGESICS X X X XNormeperidine OPIOID ANALGESICSNorpropoxyphene OPIOID ANALGESICS X X X XO‐Desmethyltramadol OPIOID ANALGESICS X X X XOxycodone OPIOID ANALGESICS X X X XOxymorphone OPIOID ANALGESICS X X X XPentazocine OPIOID ANALGESICSPropoxyphene OPIOID ANALGESICS X X X XSufentanil OPIOID ANALGESICSTapentadol OPIOID ANALGESICSTramadol OPIOID ANALGESICS X X X X1‐Hydroxymidazolam SEDATIVE/HYPNOTICSEszopiclone/Zopiclone SEDATIVE/HYPNOTICSLegend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 8 of 9 10/19/2020

Analyte Name Drug Class

Drugs of Abuse Panel, Blood

70530

Drugs of Abuse Panel, Tissue

70530T

Drugs of Abuse Panel, Fluid70530FL

Drugs of Abuse Panel, Vitreous

70530VMethaqualone SEDATIVE/HYPNOTICSSuvorexant SEDATIVE/HYPNOTICSTiletamine SEDATIVE/HYPNOTICSZaleplon SEDATIVE/HYPNOTICSZolpidem SEDATIVE/HYPNOTICSBenzoylecgonine STIMULANTS X X X XBenzylpiperazine (BZP) STIMULANTSCaffeine STIMULANTSCocaethylene STIMULANTS X X X XCocaine STIMULANTS X X X XCotinine STIMULANTSMethylphenidate STIMULANTSNicotine STIMULANTS4CN‐CUMYL‐BINACA SYNTHETIC CANNABINOIDS4F‐MDMB‐BINACA SYNTHETIC CANNABINOIDS5F‐ADB SYNTHETIC CANNABINOIDS5F‐ADB Butanoic Acid Metabolite SYNTHETIC CANNABINOIDS5F‐MDMB‐PICA SYNTHETIC CANNABINOIDSADB‐FUBINACA SYNTHETIC CANNABINOIDSFUB‐144 SYNTHETIC CANNABINOIDSFUB‐AMB SYNTHETIC CANNABINOIDSMDMB‐FUBINACA SYNTHETIC CANNABINOIDSMDMB‐FUBINACA Butanoic Acid Metabolite SYNTHETIC CANNABINOIDSN‐Desmethylsildenafil UROLOGICALSSildenafil UROLOGICALSTadalafil UROLOGICALSVardenafil UROLOGICALSYohimbine UROLOGICALSAcetone VOLATILES X X X XEthanol VOLATILES X X X XIsopropanol VOLATILES X X X XMethanol VOLATILES X X X X

Legend:X Screened and confirmed in panel* Qualitatitively reported from screenA Confirmation offered through Analyte Assurance™ Page 9 of 9 10/19/2020

BASIC DRUGS OF ABUSE, URINE

(included with DOA and Comprehensive Panels)

317-759-4TOX | AXISFORTOX.COM | [email protected]

Drug Class Analyte Name

AMPHETAMINES Amphetamine

AMPHETAMINES MDMA

AMPHETAMINES Methamphetamine

BENZODIAZEPINES 7-Aminoclonazepam

BENZODIAZEPINES Alpha-Hydroxyalprazolam

BENZODIAZEPINES Alprazolam

BENZODIAZEPINES Lorazepam

BENZODIAZEPINES Nordiazepam

BENZODIAZEPINES Oxazepam

BENZODIAZEPINES Temazepam

HALLUCINOGENS Phencyclidine

MUSCLE RELAXANTS Meprobamate

OPIOID ANALGESICS 6-Acetylmorphine

OPIOID ANALGESICS Buprenorphine

OPIOID ANALGESICS Codeine

OPIOID ANALGESICS EDDP

OPIOID ANALGESICS Fentanyl

OPIOID ANALGESICS Hydrocodone

OPIOID ANALGESICS Hydromorphone

OPIOID ANALGESICS Methadone

OPIOID ANALGESICS Morphine

OPIOID ANALGESICS Norbuprenorphine

OPIOID ANALGESICS Norfentanyl

OPIOID ANALGESICS O-Desmethyltramadol

OPIOID ANALGESICS Oxycodone

OPIOID ANALGESICS Oxymorphone

OPIOID ANALGESICS Tramadol

STIMULANTS Benzoylecgonine

Results reported qualitatively via mass spectrometry, not confirmed via alternate method. SMR155v2.0 12/21/2020